POSS, nice positive news
Possis Medical, Inc. Named One of Minnesota's Best Performing Small Public Companies
MINNEAPOLIS--(BUSINESS WIRE)--May 30, 2001--Possis Medical, Inc. (Nasdaq:POSS - news) has been named one of the Best Performing Small Companies in Minnesota by Ventures magazine. Possis ranked number fifteen on the Ventures list, which measured the four fiscal quarters ending March 31, 2001. The criteria included percent revenue growth; dollar revenue growth; percent income growth, scaled by revenue; percent growth in total assets; and total return to shareholders.
Possis Medical's CEO, Robert G. Dutcher received the award at an event sponsored by Robert Half International, Lawson Software, Deloitte & Touche, and Fredrikson & Byron. Dutcher said, ``Possis recently announced record quarterly sales and achieved the important milestone of corporate profitability in its third quarter. Minnesota is a unique spawning ground for medical innovation, and this award recognizes the rapid pace at which Possis Medical has been able to expand adoption of our technology platform, the AngioJet System. I am proud to accept this award on behalf of our Company and its employees. We look forward to continuing our record of growth and performance in the future.''
Possis Medical Inc. develops, manufactures and markets pioneering medical devices for the large and growing cardiovascular and vascular treatment markets. Its primary product, the AngioJet® Rheolytic(TM) Thrombectomy System, is marketed in the United States for blood clot removal from coronary arteries and bypass grafts, leg arteries and AV dialysis access grafts. The Company is currently pursuing an additional indication for the AngioJet System in the treatment of ischemic stroke, through the TIME 1 clinical trial.
biz.yahoo.com |
